{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:10:02Z","timestamp":1791465002446,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023968","name":"NHS Grampian","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejogrb.2025.114678","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:10:02Z","timestamp":1756707002000},"page":"114678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The impact of human papillomavirus (HPV) vaccination on the risk of adverse obstetric outcomes: a data linkage study"],"prefix":"10.1016","volume":"314","author":[{"given":"Xiaoqian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-8620","authenticated-orcid":false,"given":"Maggie E.","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-9540","authenticated-orcid":false,"given":"Andrea M.F.","family":"Woolner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114678_b0005","article-title":"Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study","volume":"365","author":"Palmer","year":"2019","journal-title":"BMJ"},{"issue":"10316","key":"10.1016\/j.ejogrb.2025.114678_b0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114678_b0015","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Systemat Rev."},{"key":"10.1016\/j.ejogrb.2025.114678_b0020","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. In 2020."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114678_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijc.33189","article-title":"The European response to the WHO call to eliminate cervical cancer as a public health problem","volume":"148","author":"Arbyn","year":"2021","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114678_b0030","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1080\/21645515.2016.1183847","article-title":"Safety of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in adolescents aged 12\u201315 years: Interim analysis of a large community-randomized controlled trial","volume":"12","author":"Lehtinen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114678_b0035","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2184760","article-title":"Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials","volume":"19","author":"Goldstone","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"354","key":"10.1016\/j.ejogrb.2025.114678_b0040","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"28","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114678_b0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.2011.02944.x","article-title":"The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis","volume":"118","author":"Bruinsma","year":"2011","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114678_b0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/dem404","article-title":"Placental infection with human papillomavirus is associated with spontaneous preterm delivery","volume":"23","author":"Gomez","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2025.114678_b0055","doi-asserted-by":"crossref","unstructured":"Wiik J, Nilsson S, Karrberf C, Strander B, Jacobsson B, Sengpiel V. Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: A Swedish population-based study. 2021;18(5):e1003641.","DOI":"10.1371\/journal.pmed.1003641"},{"key":"10.1016\/j.ejogrb.2025.114678_b0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2014.09.002","article-title":"Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth","volume":"61","author":"Huang","year":"2014","journal-title":"J Clin Virology"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114678_b0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25308","article-title":"Association between Human Papillomavirus infection amoung pregnant women and preterm birth","volume":"4","author":"Niyibizi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejogrb.2025.114678_b0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12688\/wellcomeopenres.15140.1","article-title":"HPV infection and pre-term birth: a data-linkage study using Scottish Health Data","volume":"4","author":"Aldhous","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ejogrb.2025.114678_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","article-title":"Vaginal microbiome and cervical cancer","volume":"86","author":"Kyrgiou","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114678_b0080","first-page":"630","article-title":"Meta-analysis of the correlation between vaginal microenvironment and HPV infection","volume":"15","author":"Fu","year":"2023","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114678_b0085","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41591-019-0450-2","article-title":"The vaginal microbiome and preterm birth","volume":"25","author":"Fettweis","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ejogrb.2025.114678_b0090","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation, (UN IGME). 1 Levels & Trends in Child Mortality: Report 2019, Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. United Nations Children\u2019s Fund 2019:https:\/\/www.unicef.org\/media\/60561\/file\/UN\u20132019.pdf."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114678_b0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ije\/dyv356","article-title":"Data resource profile: the aberdeen maternity and neonatal databank (AMND)","volume":"45","author":"Ayorinde","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejogrb.2025.114678_b0100","unstructured":"Scottish Government. Scottish Index of Multiple Deprivation 2016: introductory booklet. 2016; Available at: https:\/\/www.gov.scot\/publications\/scottish-index-multiple-deprivation-2016\/. Accessed 09\/22, 2022."},{"key":"10.1016\/j.ejogrb.2025.114678_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106473","article-title":"Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial","volume":"146","author":"Kalliala","year":"2021","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114678_b0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/infdis\/jiaa106","article-title":"Has human papillomavirus (HPV) vaccination prevented adverse pregnancy outcomes? Population-level analysis after 8 years of a national HPV vaccination program in Australia","volume":"222","author":"Yuill","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2025.114678_b0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/1471-0528.17349","article-title":"Spontaneous preterm birth risk among HPV-vaccinated and unvaccinated women: a nationwide retrospective cohort study of over 240,000 singleton births","volume":"130","author":"McClymont","year":"2023","journal-title":"BJOG"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114678_b0120","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/aogs.13190","article-title":"Human papillomavirus infects placental trophoblast and Hofbauer cells, but appears not to play a causal role in miscarriage and preterm labor","volume":"96","author":"Amb\u00fchl","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114678_b0125","first-page":"138.e1","article-title":"High risk human papillomavirus at entry to prenatal care and risk of preeclampsia","volume":"210","author":"McDonnold","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114678_b0130","doi-asserted-by":"crossref","unstructured":"Cho G, Min KJ, Hong HR, et al. High-risk human papillomavirus infection is associated with premature rupture of membranes. 2013;13(173).","DOI":"10.1186\/1471-2393-13-173"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114678_b0135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/andr.12948","article-title":"Seminal human papillomavirus infection and reproduction: a systematic review and meta-analysis","volume":"9","author":"Moreno-Sepulveda","year":"2021","journal-title":"Andrology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:32:27Z","timestamp":1760365947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525009546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["S0301211525009546"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114678","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of human papillomavirus (HPV) vaccination on the risk of adverse obstetric outcomes: a data linkage study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114678"}}